BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36536335)

  • 1. Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya.
    Mutisya EM; Muturi-Kioi V; Abaasa A; Nyasani D; Kabuti RW; Lunani L; Kotikot T; Mundia M; Mutua G; Ombati G; Nduta H; Price MA; Kimani J; Anzala AO
    BMC Public Health; 2022 Dec; 22(1):2385. PubMed ID: 36536335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
    PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.
    Abaasa A; Nash S; Mayanja Y; Price M; Fast PE; Kamali A; Kaleebu P; Todd J
    Vaccine; 2019 Apr; 37(15):2065-2072. PubMed ID: 30857933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance.
    Manguro GO; Musau AM; Were DK; Tengah S; Wakhutu B; Reed J; Plotkin M; Luchters S; Gichangi P; Temmerman M
    BMC Public Health; 2022 Feb; 22(1):304. PubMed ID: 35164707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
    Price MA; Rida W; Mwangome M; Mutua G; Middelkoop K; Roux S; Okuku HS; Bekker LG; Anzala O; Ngugi E; Stevens G; Chetty P; Amornkul PN; Sanders EJ
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):185-93. PubMed ID: 22227488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of retention in observational cohorts and nested simulated HIV vaccine efficacy trials in the key populations in Uganda.
    Abaasa A; Todd J; Nash S; Mayanja Y; Kaleebu P; Fast PE; Price M
    BMC Med Res Methodol; 2020 Feb; 20(1):32. PubMed ID: 32050900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the size of key populations at risk for HIV infection: men who have sex with men, female sex workers and injecting drug users in Nairobi, Kenya.
    Okal J; Geibel S; Muraguri N; Musyoki H; Tun W; Broz D; Kuria D; Kim A; Oluoch T; Raymond HF
    Sex Transm Infect; 2013 Aug; 89(5):366-71. PubMed ID: 23761166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of sexual, physical and verbal assaults on men who have sex with men and female sex workers in coastal Kenya.
    Micheni M; Rogers S; Wahome E; Darwinkel M; van der Elst E; Gichuru E; Graham SM; Sanders EJ; Smith AD
    AIDS; 2015 Dec; 29 Suppl 3(0 3):S231-6. PubMed ID: 26562812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
    Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in sub-Saharan Africa (HPTN 075).
    Sandfort TG; L Hamilton E; Marais A; Guo X; Sugarman J; Chen YQ; Cummings V; Dadabhai S; Dominguez K; Panchia R; Schnabel D; Zulu F; Reynolds D; Radebe O; Mbeda C; Kamba D; Kanyemba B; Ogendo A; Stirratt M; Chege W; Lucas J; Fawzy M; McKinstry LA; Eshleman SH
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25600. PubMed ID: 33000911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of propensity score matching to create counterfactual group to assess potential HIV prevention interventions.
    Abaasa A; Mayanja Y; Asiki G; Price MA; Fast PE; Ruzagira E; Kaleebu P; Todd J
    Sci Rep; 2021 Mar; 11(1):7017. PubMed ID: 33782485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for loss to follow-up among at-risk HIV negative men who have sex with men participating in a research cohort with access to pre-exposure prophylaxis in coastal Kenya.
    Wahome EW; Graham SM; Thiong'o AN; Mohamed K; Oduor T; Gichuru E; Mwambi J; van der Elst EM; Sanders EJ
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25593. PubMed ID: 33000889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya.
    Musyoki H; Bhattacharjee P; Sabin K; Ngoksin E; Wheeler T; Dallabetta G
    J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25729. PubMed ID: 34189847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspareunia, signs of epithelial disruption, sexual abstinence, and HIV status in female sex workers in Nairobi: a cross-sectional study.
    Fischer B; Jaoko W; Kirui E; Muture B; Madegwa I; Kageni L
    BMC Infect Dis; 2023 Sep; 23(1):569. PubMed ID: 37658320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria.
    Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T
    BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya.
    Achwoka D; Oyugi JO; Mutave R; Munywoki P; Achia T; Akolo M; Muriuki F; Muthui M; Kimani J
    PLoS One; 2020; 15(7):e0235606. PubMed ID: 32614906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High HIV risk in a cohort of male sex workers from Nairobi, Kenya.
    McKinnon LR; Gakii G; Juno JA; Izulla P; Munyao J; Ireri N; Kariuki CW; Shaw SY; Nagelkerke NJ; Gelmon L; Musyoki H; Muraguri N; Kaul R; Lorway R; Kimani J
    Sex Transm Infect; 2014 May; 90(3):237-42. PubMed ID: 24337729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.
    Calin R; Massari V; Pialoux G; Reydellet N; Plenel E; Chauvin C; Jauffret-Roustide M; Day N; Kreplak G; Maresca AF; Derche N; Louis S; Pol S; Doré V; Rouzioux C; Chauvin P
    BMC Infect Dis; 2020 Nov; 20(1):851. PubMed ID: 33198672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.